Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price reached a new 52-week low during trading on Monday . The company traded as low as C$0.13 and last traded at C$0.13, with a volume of 192568 shares trading hands. The stock had previously closed at C$0.15.
Voyageur Pharmaceuticals Price Performance
The company has a debt-to-equity ratio of 2.77, a current ratio of 0.58 and a quick ratio of 0.84. The stock’s 50 day moving average price is C$0.16 and its two-hundred day moving average price is C$0.16. The firm has a market capitalization of C$26.77 million, a price-to-earnings ratio of -7.50 and a beta of 0.78.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- The “secret weapon” behind Microsoft, Meta, Amazon, and Google
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- The U.S. Military’s “Ace Card” For Iran
- Iran isn’t the real war
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
